FDA advisers recommend approving Arena weight–loss drug
It is supposed to be used in combination with a healthy diet and exercise. Patients who started the locaserin trials lost an average of 5% of their weight; those who completed the studies lost an average of 8%, says company spokesman David Schull. See all stories on this topic » |
USA TODAY |